• Something wrong with this record ?

The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries

Z. Kutil, L. Skultetyova, D. Rauh, M. Meleshin, I. Snajdr, Z. Novakova, J. Mikesova, J. Pavlicek, M. Hadzima, P. Baranova, B. Havlinova, P. Majer, M. Schutkowski, C. Barinka,

. 2019 ; 33 (3) : 4035-4045. [pub] 20181129

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Histone deacetylase 6 (HDAC6) is a multidomain cytosolic hydrolase acting mostly on nonhistone protein substrates. Investigations of the substrate specificity of HDAC6 are confounded by the presence of 2 catalytically active deacetylase domains (DD1 and DD2). In this study, acetylome peptide microarrays and peptide libraries were used to map the substrate specificity of DD1 and DD2 of human HDAC6. The results show that DD1 is solely responsible for the deacetylation of substrates harboring the acetyllysine at their C terminus, whereas DD2 exclusively deacetylates peptides with an internal acetyllysine residue. Also, statistical analysis of the deacetylation data revealed amino acid preferences at individual positions flanking the acetyllysine, where glycine and arginine residues are favored at positions N-terminal to the central acetyllysine; negatively charged glutamate is strongly disfavored throughout the sequence. Finally, the deacylation activity of HDAC6 was profiled by using a panel of acyl derivatives of the optimized peptide substrate and showed that HDAC6 acts as a proficient deformylase. Our data thus offer a detailed insight into the substrate preferences of the individual HDAC6 domains at the peptide level, and these findings can in turn help in elucidating the biologic roles of the enzyme and facilitate the development of new domain-specific inhibitors as research tools or therapeutic agents.-Kutil, Z., Skultetyova, L., Rauh, D., Meleshin, M., Snajdr, I., Novakova, Z., Mikesova, J., Pavlicek, J., Hadzima, M., Baranova, P., Havlinova, B., Majer, P., Schutkowski, M., Barinka, C. The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20022857
003      
CZ-PrNML
005      
20201214124902.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1096/fj.201801680R $2 doi
035    __
$a (PubMed)30496698
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kutil, Zsofia $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
245    14
$a The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries / $c Z. Kutil, L. Skultetyova, D. Rauh, M. Meleshin, I. Snajdr, Z. Novakova, J. Mikesova, J. Pavlicek, M. Hadzima, P. Baranova, B. Havlinova, P. Majer, M. Schutkowski, C. Barinka,
520    9_
$a Histone deacetylase 6 (HDAC6) is a multidomain cytosolic hydrolase acting mostly on nonhistone protein substrates. Investigations of the substrate specificity of HDAC6 are confounded by the presence of 2 catalytically active deacetylase domains (DD1 and DD2). In this study, acetylome peptide microarrays and peptide libraries were used to map the substrate specificity of DD1 and DD2 of human HDAC6. The results show that DD1 is solely responsible for the deacetylation of substrates harboring the acetyllysine at their C terminus, whereas DD2 exclusively deacetylates peptides with an internal acetyllysine residue. Also, statistical analysis of the deacetylation data revealed amino acid preferences at individual positions flanking the acetyllysine, where glycine and arginine residues are favored at positions N-terminal to the central acetyllysine; negatively charged glutamate is strongly disfavored throughout the sequence. Finally, the deacylation activity of HDAC6 was profiled by using a panel of acyl derivatives of the optimized peptide substrate and showed that HDAC6 acts as a proficient deformylase. Our data thus offer a detailed insight into the substrate preferences of the individual HDAC6 domains at the peptide level, and these findings can in turn help in elucidating the biologic roles of the enzyme and facilitate the development of new domain-specific inhibitors as research tools or therapeutic agents.-Kutil, Z., Skultetyova, L., Rauh, D., Meleshin, M., Snajdr, I., Novakova, Z., Mikesova, J., Pavlicek, J., Hadzima, M., Baranova, P., Havlinova, B., Majer, P., Schutkowski, M., Barinka, C. The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries.
650    12
$a katalytická doména $7 D020134
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a histondeacetylasa 6 $x chemie $x metabolismus $7 D000073864
650    _2
$a lidé $7 D006801
650    _2
$a lysin $x chemie $x metabolismus $7 D008239
650    _2
$a peptidové fragmenty $x chemie $x metabolismus $7 D010446
650    _2
$a vazba proteinů $7 D011485
650    _2
$a statická elektřina $7 D055672
650    _2
$a substrátová specifita $7 D013379
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Skultetyova, Lubica $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Rauh, David $u Department of Enzymology, Charles Tanford Protein Center, Institute for Biochemistry and Biotechnology, Martin Luther University, Halle (Saale), Germany; and.
700    1_
$a Meleshin, Marat $u Department of Enzymology, Charles Tanford Protein Center, Institute for Biochemistry and Biotechnology, Martin Luther University, Halle (Saale), Germany; and.
700    1_
$a Snajdr, Ivan $u Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic.
700    1_
$a Novakova, Zora $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Mikesova, Jana $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Pavlicek, Jiri $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Hadzima, Martin $u Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic.
700    1_
$a Baranova, Petra $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Havlinova, Barbora $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Majer, Pavel $u Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic.
700    1_
$a Schutkowski, Mike $u Department of Enzymology, Charles Tanford Protein Center, Institute for Biochemistry and Biotechnology, Martin Luther University, Halle (Saale), Germany; and.
700    1_
$a Barinka, Cyril $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
773    0_
$w MED00001782 $t FASEB journal : official publication of the Federation of American Societies for Experimental Biology $x 1530-6860 $g Roč. 33, č. 3 (2019), s. 4035-4045
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30496698 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214124902 $b ABA008
999    __
$a ok $b bmc $g 1595176 $s 1113533
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 33 $c 3 $d 4035-4045 $e 20181129 $i 1530-6860 $m The FASEB journal $n FASEB J $x MED00001782
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...